Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: The EBMT experience

Annals of Oncology

Volumn 16, Issue 1, 2005, Pages 146-151

  De Giorgi, Ugo ^a   Demirer, T ^b   Wandt, H ^c   Taverna, C ^d   Siegert, W ^e   Bornhauser, M ^f   Kozak, T ^g   Papiani, G ^a   Ballardini, M ^h   Rosti, G ^a   Marangolo, M ^a   Ehninger, G ^f   Suttorp, M ^f   Carus, Carl Gustav ^f   Lutz, D ⁱ   Schwarer, A P ^j   Thyss, A ^k   Ludwig, H ^l   Baumgartner, G ^l   Lioure, B ^m   Gratwohl, A ⁿ   Hertenstein, B ^o   Welte, K ^o   Blasczyk, R ^o   Beguin, Y ^p   Metzner, B ^q   Orchard, K ^r   Garcia Conde, J ^s   Devalck, C ^t   Moicean, A D ^u   Marcus, R ^v   McCann, S ^w   Schey, S A ^x   Juliusson, G ^y   Lenhoff, S ^z   Kolbe, K ^aa   Morra, E ^ab   Rossi, J F ^ac   Yaniv, I ^ad   Koza, V ^ae   Freund, M ^af   Bjorkholm, M ^ag   Greinix, H ^ah   Hinterberger, W ^ai   more..

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^b ANKARA UNIVERSITY   (Turkey)

^c KLINIKUM NÜRNBERG   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g CHARLES UNIVERSITY   (Czech Republic)

^h ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

ⁱ ELISABETHINEN HOSPITAL   (Austria)

^j ALFRED HOSPITAL   (Australia)

^k CENTRE ANTOINE LACASSAGNE   (France)

^l WILHELMINEN HOSPITAL   (Austria)

^m UNIVERSITY HOSPITAL OF STRASBOURG   (France)

ⁿ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^o HANNOVER MEDICAL SCHOOL   (Germany)

^p UNIVERSITY OF LIÈGE   (Belgium)

^q UNIVERSITY OF OLDENBURG   (Germany)

^r SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^s Anestesiology Department University Hospital Geral   (Spain)

^t SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^u VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^v ADDENBROOKE S HOSPITAL   (United Kingdom)

^w ST JAMES S HOSPITAL   (Ireland)

^x KING'S COLLEGE LONDON   (United Kingdom)

^y LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^z LUND UNIVERSITY HOSPITAL   (Sweden)

^aa JOHANNES GUTENBERG UNIVERSITY   (Germany)

^ab OSPEDALE NIGUARDA CA GRANDA   (Italy)

^ac MONTPELLIER UNIVERSITY HOSPITAL   (France)

^ad Child Developmental Center   (Israel)

^ae CHARLES UNIVERSITY   (Czech Republic)

^af ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^ag KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ah UNIVERSITY OF VIENNA   (Austria)

^ai DANUBE HOSPITAL   (Austria)

more..

Author keywords

EBMT; Extragonadal; High dose chemotherapy; Non seminomatous germ cell tumor; Second line chemotherapy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; PLATINUM DERIVATIVE; THIOTEPA; VINBLASTINE;

ADULT; ARTICLE; BLEEDING DISORDER; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG FATALITY; DRUG MEGADOSE; EUROPE; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; INFECTION; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MEDIASTINUM TUMOR; MEDICAL DECISION MAKING; MYELODYSPLASIA; NEPHROTOXICITY; NEUROTOXICITY; NON SEMINOMATOUS GERMINOMA; OTOTOXICITY; PERIPHERAL NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETROPERITONEAL TUMOR; RETROSPECTIVE STUDY; SECOND CANCER; TREATMENT PLANNING; TUMOR RECURRENCE; VEIN OCCLUSION;

EID: 19944427229     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi017     Document Type: Article

References (17)

1. Collins DH, Pugh RCB. Classification and frequency of testicular cancer. Br J Urol 1964; 36 (Suppl 1): 1-11.
2. Hainsworth CR, Greco FA. Extragonadal germ cell tumors and unrecognized germ cell tumors. Semin Oncol 1992; 19: 119-127.
3. Nichols CR, Roth BJ, Heerema N et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990; 322: 1425-1429.
4. Hartmann JT, Nichols CR, Droz JP et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst 2000; 92: 54-61.
5. Vuky J, Bains M, Bacik J et al. Role of post-chemotherapy surgery in the management of patients with noseminoma arising from the mediastinum. J Clin Oncol 2001; 19: 682-688.
6. International Germ Cell Consensus Classification. A prognostic factor-based staging system for metastatic germ cell cancers-International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594-603.
7. Hartmann JT, Einhorn L, Nichols CR et al. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. J Clin Oncol 2001; 19: 1641-1648.
8. Fossa SD, Stenning SP, Gerl A et al. Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 1999; 80: 1392-1399.
9. Beyer J, Kramar A, Mandanas R et al. High-dose chemotherapy as salvage treatment in germ cell tumors: A multivariate analysis of prognostic variables. J Clin Oncol 1996; 14: 2638-2645.
10. Miller AB, Hoogstraten B, Staquet M, Winckler A. Reporting results of anticancer treatment. Cancer 1981; 47: 207-214.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Cox DR. Regression models and life tablets. J R Stat Soc B 1972; 3: 187-202.
13. Loehrer PJ, Gonin R, Nichols CR et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998; 16: 2500-2504.
14. Saxman S, Nichols CR, Einhorn LH et al. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience. J Clin Oncol 1994; 12: 1390-1393.
15. Vaena DA, Abonour R, Einhorn LH. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. J Clin Oncol 2003; 21: 4100-4104.
16. De Giorgi U, Rosti G, Papiani G et al. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in patients with germ cell tumor. Haematologica 2002; 87: 95-104.
17. Rosti G, Pico JL, Wandt H et al. High-dose chemotherapy (HDC) in the salvage treatment of patients failing first-line platinum-based chemotherapy for advanced germ cell tumors (GCT); first results of a prospective randomised trial of the European Group for Blood and Marrow Transplantation (EBMT): IT-94 study. Proc Am Soc Clin Oncol 2002; 21: 180a (Abstr 716).